Effects of erythropoiesis stimulating agentin on heart failure patients with reduced left ventricular function and the cardiorenal anemia syndrome
Not Applicable
- Conditions
- Chronic heart failure patients with reduced left ventricular function
- Registration Number
- JPRN-UMIN000010762
- Lead Sponsor
- Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. uncontrolled hypertension (>160/100 mmHg) 2. previous history of cardiovascular disease within 3 months 3. new-onset of atrial fibrillation and atrial flutter within one month 4. Cr>3mg/dl 5. renal transplantation within 6 months, or chemo and radiation therapy within 12 months. Previous history of malignant disease, hematological disorder. 6. allergy of ESA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sudden cardiac death, death and hospitalization due to worsening heart failure
- Secondary Outcome Measures
Name Time Method